electroCore to Present at H.C. Wainwright BIOCONNECT Virtual Conference
January 04, 2022 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Jan. 04, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will...
electroCore, Inc. Provides Update on Global Distribution Partners
December 16, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 16, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced it has entered into agreements...
electroCore, Inc. Announces The Launch of a New Online Shop in the United Kingdom
December 15, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 15, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced the launch of an e-commerce...
electroCore, Inc. Provides Update on nVNS to Treat Post Traumatic Stress Disorder
December 14, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 14, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today provided an update on the ongoing...
electroCore Announces New Patent for Stroke and TIA Treatment
December 13, 2021 08:55 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 13, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent...
electroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum
November 11, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Nov. 11, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will be...
electroCore Announces Third Quarter 2021 Financial Results
November 04, 2021 16:01 ET
|
electroCore, Inc.
Third quarter 2021 revenue grew 17% sequentially and 38% over third quarter 2020 Company to host a conference call and webcast today, November 4, 2021 at 4:30 pm ET ROCKAWAY, N.J., Nov. 04, 2021 ...
electroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th
October 21, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the third...
electroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England
October 20, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Oct. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper entitled...
electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine
October 14, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Oct. 14, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that the company received an amended Medical...